Intuitive Surgical Inc (ISRG)
527.61
-10.19
(-1.89%)
USD |
NASDAQ |
Nov 15, 16:00
528.07
+0.46
(+0.09%)
After-Hours: 20:00
Intuitive Surgical Research and Development Expense (TTM): 1.111B for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.111B |
| June 30, 2024 | 1.074B |
| March 31, 2024 | 1.038B |
| December 31, 2023 | 998.80M |
| September 30, 2023 | 982.80M |
| June 30, 2023 | 950.50M |
| March 31, 2023 | 913.40M |
| December 31, 2022 | 879.00M |
| September 30, 2022 | 818.30M |
| June 30, 2022 | 766.70M |
| March 31, 2022 | 721.70M |
| December 31, 2021 | 671.00M |
| September 30, 2021 | 637.40M |
| June 30, 2021 | 626.90M |
| March 31, 2021 | 607.80M |
| December 31, 2020 | 595.10M |
| September 30, 2020 | 601.90M |
| June 30, 2020 | 582.80M |
| March 31, 2020 | 560.40M |
| December 31, 2019 | 557.30M |
| September 30, 2019 | 520.60M |
| June 30, 2019 | 492.30M |
| March 31, 2019 | 466.60M |
| December 31, 2018 | 418.10M |
| September 30, 2018 | 385.30M |
| Date | Value |
|---|---|
| June 30, 2018 | 361.10M |
| March 31, 2018 | 350.60M |
| December 31, 2017 | 328.60M |
| September 30, 2017 | 310.60M |
| June 30, 2017 | 289.80M |
| March 31, 2017 | 259.90M |
| December 31, 2016 | 239.60M |
| September 30, 2016 | 223.10M |
| June 30, 2016 | 211.50M |
| March 31, 2016 | 206.20M |
| December 31, 2015 | 197.40M |
| September 30, 2015 | 192.10M |
| June 30, 2015 | 188.60M |
| March 31, 2015 | 179.40M |
| December 31, 2014 | 178.00M |
| September 30, 2014 | 172.40M |
| June 30, 2014 | 168.10M |
| March 31, 2014 | 169.10M |
| December 31, 2013 | 167.70M |
| September 30, 2013 | 167.70M |
| June 30, 2013 | 174.20M |
| March 31, 2013 | 173.20M |
| December 31, 2012 | 170.00M |
| September 30, 2012 | 169.70M |
| June 30, 2012 | 155.40M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
557.30M
Minimum
Dec 2019
1.111B
Maximum
Sep 2024
784.75M
Average
744.20M
Median
Research and Development Expense (TTM) Benchmarks
| Abbott Laboratories | 2.795B |
| Becton Dickinson & Co | 1.19B |
| Masimo Corp | 183.10M |
| PROCEPT BioRobotics Corp | 61.73M |
| Perspective Therapeutics Inc | 28.53M |